The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and liquid-based cytology (LBC) as primary screening tests. Each woman with a positive result received colposcopy with lesion-ta...

Full description

Bibliographic Details
Main Authors: Shao-Kai Zhang, Zhen Guo, Peng Wang, Le-Ni Kang, Man-Man Jia, Ze-Ni Wu, Qiong Chen, Xiao-Qin Cao, Dong-Mei Zhao, Pei-Pei Guo, Xi-Bin Sun, Jian-Gong Zhang, You-Lin Qiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
HPV – human papillomavirus
mRNA
cervical cancer
sensitiviity
specificity
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.533253/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.533253/full

Similar Items